Renin-Angiotensin system blockers may prolong survival of metastatic non-small cell lung cancer patients receiving erlotinib. [electronic resource]
Producer: 20150820Description: e887 p. digitalISSN:- 1536-5964
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.